Obsolescence risk for lipoprotein profiling technology
First written in FY2016. 2 of 4 entries say "Restated". Latest entry: FY2020.
No other company in this theme has enough history to compare yet.
- FY2020DroppedAnnual reportThis filing's risk factors do not explicitly mention the risk of obsolescence of lipoprotein profiling technology.
- FY2019RestatedAnnual report
「However, the development of analytical technologies may give rise to more advanced technologies. If a new technology emerges, most of the competitive advantage of the business based on its lipoprotein profiling technology could be lost in a short period of time.」
The risk of obsolescence of lipoprotein profiling technology and loss of competitive advantage is reiterated. - FY2017RestatedAnnual report
「However, the development of analytical technologies may give rise to more advanced technologies. If a new technology emerges, most of the competitive advantage of the business based on its lipoprotein profiling technology could be lost in a short period of time.」
The risk of obsolescence of lipoprotein profiling technology and loss of competitive advantage is reiterated. - FY2016First statedAnnual report
「However, the development of analytical technologies may give rise to more advanced technologies. If a new technology emerges, most of the competitive advantage based on the Group's lipoprotein profiling technology could be lost in a short period of time.」
This indicates that the competitive advantage dependent on the core technology could be lost in a short period of time as a result of the emergence of new technologies.